BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) announced that it has partnered with management to recapitalize Belmont Instrument Corporation (“Belmont”), a leading provider of fluid warming infusion systems sold into acute care, military, and EMS settings. Headquartered in Billerica, MA, Belmont is a technology leader in rapid infusion systems used to treat critically injured patients experiencing material blood loss. Audax partnered with Belmont’s private owners in connection with the recapitalization.
Geoffrey S. Rehnert, Co-Chief Executive Officer, Audax Group, said, “Belmont is a best-in-class provider of life-sustaining fluid warming infusion systems. We are excited to partner with management to build on Belmont’s leading position and accelerate growth by continuing its investment in new product development, global marketing and salesforce expansion, and through acquisition of complementary patient warming and critical care medical technologies.”
Mirus Capital Advisors served as financial advisor, and Mintz Levin served as legal counsel to Belmont. Ropes & Gray served as legal counsel to Audax.
ABOUT AUDAX PRIVATE EQUITY
Since its founding in 1999, Audax Private Equity has been focused on building leading middle market companies. Audax has invested $4.5 billion in 110 platforms and 635 add-on companies. Through its disciplined Buy & Build approach, Audax seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value. Audax Private Equity is an integral part of Audax Group, an alternative asset management firm specializing in investments in middle market companies. With offices in Boston, New York, and San Francisco, Audax Group has over $11.5 billion in assets under management across its Private Equity, Mezzanine, and Senior Debt businesses. For more information, visit the Audax Group website, www.audaxgroup.com.